P Lorigan Selected Research

CAV regimen

8/2001

Randomized phase II study of cyclophosphamide, doxorubicin, and vincristine compared with single-agent carboplatin in patients with poor prognosis small cell lung carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

P Lorigan Research Topics

Disease

30	Melanoma (Melanoma, Malignant) 01/2022 - 01/2000
9	Neoplasms (Cancer) 01/2021 - 08/2000
8	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 07/2012 - 08/2001
7	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 04/2005
4	Brain Neoplasms (Brain Tumor) 01/2022 - 11/2012
3	Neutropenia 08/2008 - 08/2001
3	Infections 08/2008 - 07/2003
2	Adenocarcinoma 01/2021 - 10/2010
2	Vomiting 10/2010 - 02/2008
1	Colorectal Neoplasms (Colorectal Cancer) 01/2021
1	Lung Neoplasms (Lung Cancer) 01/2021
1	Pneumonia (Pneumonitis) 01/2021
1	Exanthema (Rash) 01/2021
1	Colitis 01/2021
1	Neoplasm Metastasis (Metastasis) 01/2018
1	Disease Progression 05/2014
1	Nausea 02/2008
1	Sarcoma (Soft Tissue Sarcoma) 01/2005
1	Thrombocytopenia (Thrombopenia) 08/2001
1	Cough 08/2001
1	Dyspnea (Shortness of Breath) 08/2001
1	Alopecia (Baldness) 08/2001
1	Sepsis (Septicemia) 08/2001
1	Trophoblastic Neoplasms (Trophoblastic Tumor) 08/2000

Drug/Important Bio-Agent (IBA)

5	Dacarbazine (DIC)FDA LinkGeneric 09/2013 - 03/2000
4	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 08/2001
3	IpilimumabIBA 01/2022 - 10/2013
3	pembrolizumabIBA 01/2022 - 10/2016
3	SteroidsIBA 01/2021 - 01/2000
3	Bevacizumab (Avastin)FDA Link 12/2019 - 01/2008
3	Carboplatin (JM8)FDA LinkGeneric 07/2012 - 08/2001
3	PlatinumIBA 10/2010 - 07/2006
3	Cisplatin (Platino)FDA LinkGeneric 10/2006 - 03/2000
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2022 - 05/2014
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2022 - 11/2012
2	Pharmaceutical PreparationsIBA 01/2021 - 01/2005
2	cyclopropapyrroloindoleIBA 01/2021 - 07/2018
2	Circulating Tumor DNAIBA 01/2019 - 01/2018
2	Biomarkers (Surrogate Marker)IBA 01/2015 - 07/2012
2	Docetaxel (Taxotere)FDA Link 05/2014 - 07/2006
2	VaccinesIBA 10/2013 - 04/2006
2	Temozolomide (Temodar)FDA LinkGeneric 04/2009 - 07/2003
2	Doxorubicin (Adriamycin)FDA LinkGeneric 08/2008 - 08/2001
2	Ifosfamide FDA LinkGeneric 08/2006 - 07/2006
2	Gemcitabine FDA Link 08/2006 - 04/2005
1	Tyrosine Kinase InhibitorsIBA 01/2022
1	Protein Kinases (Protein Kinase)IBA 01/2021
1	src-Family KinasesIBA 01/2021
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2021
1	Immune Checkpoint InhibitorsIBA 07/2018
1	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 03/2018
1	Monoclonal AntibodiesIBA 01/2018
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2018
1	NivolumabIBA 10/2016
1	Cell-Free Nucleic AcidsIBA 10/2016
1	AntibodiesIBA 10/2016
1	AZD 6244IBA 05/2014
1	plitidepsin (aplidine)IBA 09/2013
1	Etoposide (VP 16)FDA LinkGeneric 07/2012
1	Pemetrexed (MTA)FDA Link 07/2012
1	Sorafenib (BAY 43-9006)FDA Link 07/2011
1	Antineoplastic Agents (Antineoplastics)IBA 07/2011
1	olaparibIBA 03/2011
1	lomeguatribIBA 04/2009
1	O(6)-Methylguanine-DNA MethyltransferaseIBA 04/2009
1	AnthracyclinesIBA 08/2008
1	Biological ProductsIBA 02/2008
1	liposomal SPI-77IBA 10/2006
1	Mitomycin (Mitomycin-C)FDA LinkGeneric 07/2006
1	Vinblastine (Vinblastine Sulfate)FDA Link 07/2006
1	rubitecanIBA 07/2005
1	Transaminases (Aminotransferases)IBA 01/2005
1	TrabectedinIBA 01/2005
1	Interferon alpha-2 (Roferon-A)FDA Link 07/2003
1	Thalidomide (Thalomid)FDA Link 07/2003
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 08/2001
1	Vincristine (Oncovin)FDA LinkGeneric 08/2001
1	Leucovorin (Folinic Acid)FDA Link 08/2000
1	Methotrexate (Mexate)FDA LinkGeneric 08/2000
1	InterferonsIBA 03/2000
1	Carmustine (FIVB)FDA Link 03/2000
1	Tamoxifen FDA LinkGeneric 03/2000
1	Interferon-alpha (Interferon Alfa)IBA 03/2000
1	Proteins (Proteins, Gene)FDA Link 01/2000
1	AntigensIBA 01/2000
1	Fibronectins (Fibronectin)IBA 01/2000
1	alpha-MSHIBA 01/2000

Therapy/Procedure

15	Therapeutics 01/2022 - 03/2000
8	Drug Therapy (Chemotherapy) 10/2016 - 08/2000
5	Radiotherapy 01/2018 - 12/2005
4	Immunotherapy 01/2021 - 07/2018
1	Palliative Care (Palliative Therapy) 01/2014
1	Drug Tapering 10/2010
1	Lymph Node Excision (Lymph Node Dissection) 01/2008
1	Platelet Transfusion (Blood Platelet Transfusions) 08/2001
1	CAV regimen 08/2001
1	Salvage Therapy 08/2000
1	Combination Drug Therapy (Combination Chemotherapy) 03/2000